Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

984 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Mørch-Johnsen L, Faerden A, Flyckt L, Fatouros-Bergman H; Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG, Hashimoto R, Yamamori H, Fukunaga M, Preda A, De Rossi P, Piras F, Banaj N, Ciullo V, Spalletta G, Gur RE, Gur RC, Wolf DH, Satterthwaite TD, Beard LM, Sommer IE, Koops S, Gruber O, Richter A, Krämer B, Kelly S, Donohoe G, McDonald C, Cannon DM, Corvin A, Gill M, Di Giorgio A, Bertolino A, Lawrie S, Nickson T, Whalley HC, Neilson E, Calhoun VD, Thompson PM, Turner JA, Ehrlich S. Walton E, et al. Among authors: Kahn RS. Acta Psychiatr Scand. 2017 May;135(5):439-447. doi: 10.1111/acps.12718. Epub 2017 Mar 29. Acta Psychiatr Scand. 2017. PMID: 28369804 Free PMC article. Clinical Trial.
Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).
Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Pijnenborg GH, et al. Among authors: Kahn RS. Eur Neuropsychopharmacol. 2015 Jun;25(6):808-16. doi: 10.1016/j.euroneuro.2015.02.012. Epub 2015 Apr 20. Eur Neuropsychopharmacol. 2015. PMID: 25907250 Clinical Trial.
The course of brain abnormalities in schizophrenia: can we slow the progression?
van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. van Haren NE, et al. Among authors: Kahn RS. J Psychopharmacol. 2012 May;26(5 Suppl):8-14. doi: 10.1177/0269881111408964. Epub 2011 Jul 5. J Psychopharmacol. 2012. PMID: 21730018 Review.
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.
Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Morch-Johnsen L, Færden A, Flyckt L, Fatouros-Bergman H; Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG, Hashimoto R, Yamamori H, Fukunaga M, Jahanshad N, De Rossi P, Piras F, Banaj N, Spalletta G, Gur RE, Gur RC, Wolf DH, Satterthwaite TD, Beard LM, Sommer IE, Koops S, Gruber O, Richter A, Krämer B, Kelly S, Donohoe G, McDonald C, Cannon DM, Corvin A, Gill M, Di Giorgio A, Bertolino A, Lawrie S, Nickson T, Whalley HC, Neilson E, Calhoun VD, Thompson PM, Turner JA, Ehrlich S. Walton E, et al. Among authors: Kahn RS. Psychol Med. 2018 Jan;48(1):82-94. doi: 10.1017/S0033291717001283. Epub 2017 May 26. Psychol Med. 2018. PMID: 28545597 Free PMC article. Clinical Trial.
Negative priming in schizophrenia revisited.
Vink M, Ramsey NF, Raemaekers M, Kahn RS. Vink M, et al. Among authors: Kahn RS. Schizophr Res. 2005 Nov 15;79(2-3):211-6. doi: 10.1016/j.schres.2005.05.004. Epub 2005 Jun 22. Schizophr Res. 2005. PMID: 15978779
Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology.
Baaré WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS. Baaré WF, et al. Among authors: Kahn RS. Biol Psychiatry. 1999 Jun 15;45(12):1597-605. doi: 10.1016/s0006-3223(98)00266-2. Biol Psychiatry. 1999. PMID: 10376121
Furthermore, in patients, smaller total orbitofrontal gray matter volume was significantly correlated with more severe negative symptomatology (rs = -.76, p = .006). ...
Furthermore, in patients, smaller total orbitofrontal gray matter volume was significantly correlated with more severe negative symptomatolo …
Serotonin receptor responsivity in schizophrenia.
Kahn RS, Davidson M. Kahn RS, et al. Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:47-51. doi: 10.1097/00004850-199311002-00007. Int Clin Psychopharmacol. 1993. PMID: 7911140 Review. No abstract available.
Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.
van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. van Berckel BN, et al. Among authors: Kahn RS. Biol Psychiatry. 1996 Dec 15;40(12):1298-300. doi: 10.1016/S0006-3223(96)00311-3. Biol Psychiatry. 1996. PMID: 8959296 Clinical Trial. No abstract available.
984 results
Jump to page
Feedback